|
|
|
|
|
Legal status
Patent expired
| (51) | INT.CL. | A61K 31/565 | (2006.01) |
| A61K 47/14 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K 47/44 | (2006.01) |
| (11) | Number of the document | 1250138 |
| (13) | Kind of document | T |
| (96) | European patent application number | 01900186.6 |
| Date of filing the European patent application | 2001-01-08 | |
| (97) | Date of publication of the European application | 2002-10-23 |
| (45) | Date of publication and mention of the grant of the patent | 2005-10-19 |
| (46) | Date of publication of the claims translation | 2006-01-25 |
| (86) | Number | PCT/GB2001/000049 |
| Date | 2001-01-08 |
| (87) | Number | WO 2001/051056 |
| Date | 2001-07-19 |
| (30) | Number | Date | Country code |
| 0000313 | 2000-01-10 | GB | |
| 0008837 | 2000-04-12 | GB |
| (72) |
EVANS, John, Raymond, GB
GRUNDY, Rosalind, Ursula, GB
|
| (73) |
AstraZeneca AB,
151 85 Södertälje,
SE
|
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | Fulvestranto kompozicija |
| FULVESTRANT FORMULATION |
| Payment date | Validity (years) | Amount | |
| 2019-12-30 | 20 | 347.00 EUR |